A citation-based method for searching scientific literature

Maran Ilanchezhian, Sophia Khan, Christian Okafor, John Glod, Jaydira Del Rivero. Horm Metab Res 2020
Times Cited: 4







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
50

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.
Alain Ravaud, Christelle de la Fouchardière, Philippe Caron, Adelaïde Doussau, Christine Do Cao, Julien Asselineau, Patrice Rodien, Damien Pouessel, Patricia Nicolli-Sire, Marc Klein,[...]. Eur J Cancer 2017
66
50

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Samuel A Wells, Jessica E Gosnell, Robert F Gagel, Jeffrey Moley, David Pfister, Julie A Sosa, Michael Skinner, Annetta Krebs, James Vasselli, Martin Schlumberger. J Clin Oncol 2010
352
50

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
50

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
50

Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
Vladimir Vasilev, Adrian F Daly, Sabina Zacharieva, Albert Beckers. Horm Metab Res 2020
8
25

AIP mutation in pituitary adenomas in the 18th century and today.
Harvinder S Chahal, Karen Stals, Martina Unterländer, David J Balding, Mark G Thomas, Ajith V Kumar, G Michael Besser, A Brew Atkinson, Patrick J Morrison, Trevor A Howlett,[...]. N Engl J Med 2011
91
25

Medical Treatment of Gastrointestinal Neuroendocrine Neoplasms.
Marina Tsoli, Krystallenia Alexandraki, Christos Xanthopoulos, Eva Kassi, Gregory Kaltsas. Horm Metab Res 2020
3
33




Research Progress on lncRNA Functions and Mechanisms in Pituitary Adenomas.
Qiu Du, De-Shan Yao, You-Wei Wang, Cheng Cheng. Horm Metab Res 2020
3
33

Optical Imaging Technology: A Useful Tool to Identify Remission in Cushing Disease After Surgery.
Ali Afshari, Margaret Keil, Charalampos Lyssikatos, Elena Belyavskaya, Nuria Valdés, Fatima A Chowdhry, Kian Parsa, Yasaman Ardeshirpour, Randall Pursley, Siddharth Khare,[...]. Horm Metab Res 2019
1
100

Cyclopes and Giants: From Homer's Odyssey to contemporary genetic diagnosis.
Georgios K Markantes, Anastasia Theodoropoulou, Anastasia K Armeni, Vasiliki Vasileiou, Constantine A Stratakis, Neoklis A Georgopoulos. Hormones (Athens) 2016
3
33

Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.
Samuel W Plaska, Chia-Jen Liu, Jung Soo Lim, Juilee Rege, Nolan R Bick, Antonio M Lerario, Gary D Hammer, Thomas J Giordano, Tobias Else, Scott A Tomlins,[...]. Horm Metab Res 2020
7
25

Cushing's Syndrome: A Historic Review of the Treatment Strategies and Corresponding Outcomes in a Single Tertiary Center over the Past Half-Century.
Anelia Nankova, Maria Yaneva, Atanaska Elenkova, Dimitar Tcharaktchiev, Marin Marinov, Asen Hadzhiyanev, Tanyo Sechanov, Georgi Gantchev, Georgi Todorov, Georgi Kirilov,[...]. Horm Metab Res 2018
3
33

Updates on the Management of Thyroid Cancer.
Katherine A Araque, Sriram Gubbi, Joanna Klubo-Gwiezdzinska. Horm Metab Res 2020
36
25

Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
Kosmas Daskalakis, Marina Tsoli, Krystallenia I Alexandraki, Anna Angelousi, Eleftherios Chatzellis, Apostolos V Tsolakis, Ioannis Karoumpalis, Denise Kolomodi, Evanthia Kassi, Gregory Kaltsas. Horm Metab Res 2019
6
25

Insulin's discovery: new insights on its ninetieth birthday.
Jesse Roth, Sana Qureshi, Ian Whitford, Mladen Vranic, C Ronald Kahn, I George Fantus, John H Dirks. Diabetes Metab Res Rev 2012
21
25


Quality of Life but not Cognition is Impacted by Radiotherapy in Patients with Non-Functioning Pituitary Adenoma.
Genevieve Crouzeix, Rémy Morello, Juliette Thariat, Julia Morera, Michael Joubert, Yves Reznik. Horm Metab Res 2019
3
33



Ernest Starling and the discovery of secretin.
I M Modlin, M Kidd. J Clin Gastroenterol 2001
6
25

Updates in the Medical Treatment of Pituitary Adenomas.
Monica Livia Gheorghiu, Francesca Negreanu, Maria Fleseriu. Horm Metab Res 2020
12
25


The History of Acromegaly.
Wouter W de Herder. Neuroendocrinology 2016
29
25

Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
L T Wu, S D Averbuch, D W Ball, A de Bustros, S B Baylin, W P McGuire. Cancer 1994
79
25

The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid.
M F Saad, N G Ordonez, J J Guido, N A Samaan. J Clin Endocrinol Metab 1984
77
25

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Jaydira Del Rivero, Maureen Edgerly, Jean Ward, Ravi A Madan, Sanjeeve Balasubramaniam, Tito Fojo, Ann W Gramza. Oncologist 2019
9
25

Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Johannes A A Meijer, Saskia le Cessie, Wilbert B van den Hout, Job Kievit, Johannes W Schoones, Johannes A Romijn, Johannes W A Smit. Clin Endocrinol (Oxf) 2010
95
25


Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.
Lawrence Fong, Peter Carroll, Vivian Weinberg, Stephen Chan, Jera Lewis, John Corman, Christopher L Amling, Robert A Stephenson, Jeffrey Simko, Nadeem A Sheikh,[...]. J Natl Cancer Inst 2014
134
25


Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.
Juan Fu, Ian-James Malm, Deepak K Kadayakkara, Hy Levitsky, Drew Pardoll, Young J Kim. Cancer Res 2014
91
25

Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma.
S Müller, D Poehnert, J A Müller, G W F Scheumann, M Koch, R Lück. World J Surg 2010
13
25

Cellular immune responses in familial medullary thyroid carcinoma.
R E Rocklin, R Gagel, Z Feldman, A H Tashjian. N Engl J Med 1977
27
25

Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
C Eng, L M Mulligan, C S Healey, C Houghton, A Frilling, F Raue, G A Thomas, B A Ponder. Cancer Res 1996
136
25

Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.
Jill J Bastman, Hilary S Serracino, Yuwen Zhu, Michelle R Koenig, Valerica Mateescu, Sharon B Sams, Kurtis D Davies, Christopher D Raeburn, Robert C McIntyre, Bryan R Haugen,[...]. J Clin Endocrinol Metab 2016
87
25

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
Christopher R Heery, Nuhad K Ibrahim, Philip M Arlen, Mahsa Mohebtash, James L Murray, Kimberly Koenig, Ravi A Madan, Sheri McMahon, Jennifer L Marté, Seth M Steinberg,[...]. JAMA Oncol 2015
58
25

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.
Marijo Bilusic, Christopher R Heery, Philip M Arlen, Myrna Rauckhorst, David Apelian, Kwong Y Tsang, Jo A Tucker, Caroline Jochems, Jeffrey Schlom, James L Gulley,[...]. Cancer Immunol Immunother 2014
63
25

Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.
Renee N Donahue, Lauren M Lepone, Italia Grenga, Caroline Jochems, Massimo Fantini, Ravi A Madan, Christopher R Heery, James L Gulley, Jeffrey Schlom. J Immunother Cancer 2017
63
25



Guidelines for diagnosis and therapy of MEN type 1 and type 2.
M L Brandi, R F Gagel, A Angeli, J P Bilezikian, P Beck-Peccoz, C Bordi, B Conte-Devolx, A Falchetti, R G Gheri, A Libroia,[...]. J Clin Endocrinol Metab 2001
25

ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.
Francesca Carlomagno, Donata Vitagliano, Teresa Guida, Fortunato Ciardiello, Giampaolo Tortora, Giancarlo Vecchio, Anderson J Ryan, Gabriella Fontanini, Alfredo Fusco, Massimo Santoro. Cancer Res 2002
482
25


Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
Christopher R Heery, B Harpreet Singh, Myrna Rauckhorst, Jennifer L Marté, Renee N Donahue, Italia Grenga, Timothy C Rodell, William Dahut, Philip M Arlen, Ravi A Madan,[...]. Cancer Immunol Res 2015
85
25

Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
M F Saad, N G Ordonez, R K Rashid, J J Guido, C S Hill, R C Hickey, N A Samaan. Medicine (Baltimore) 1984
382
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.